Infectious Diseases

Developing Medicines for Infectious Diseases

60° Pharmaceuticals (60P) continues to fulfill its promise of developing medicines for infectious diseases. Such diseases include COVID-19, babesiosis, fungal diseases, malaria, and dengue fever.* Despite competitive drug development pipelines for these diseases, critical gaps remain.

*ARAKODA has not been reviewed or approved by the U.S. Food and Drug Administration for the treatment or prevention of COVID-19, babesiosis, or fungal diseases.
90,000,000+

Cases and 1 Million deaths in the U.S. from COVID-19 infections

627,000

Annual deaths from malaria globally

125,000,000

Travelers to endemic regions per annum

390,000,000

Dengue infections per year

202-327-5422

1025 Connecticut Ave. NW, Suite 1000, Washington, DC 20036